1.44
Biovie Inc Aktie (BIVI) Neueste Nachrichten
Small cap wrap: First Phosphate, Miivo Holdings, 1911 Gold, BioVie… - Proactive financial news
BioVie completes enrollment in Long COVID trial as need for treatments grows - Proactive financial news
BioVie completes enrollment in Phase 2 Long COVID trial - Proactive financial news
BioVie (BIVI) Completes Enrollment for Phase 2 Trial of Bezister - GuruFocus
BioVie completes enrollment in Long COVID treatment trial By Investing.com - Investing.com Canada
Long COVID patients await results as BioVie trial hits full enrollment - Stock Titan
BioVie Inc. (BIVI) Gains 2.7% as Shares Test Near-Term ResistanceCTA Positioning - Newser
BioVie Inc. (BIVI) Q1 2026 Earnings: Narrowing Losses and Clinical Progress Buoy Investor SentimentStrong Earnings Momentum - Newser
BioVie Inc.Common stock (NQ: BIVI - The Chronicle-Journal
BioVie Stock Pops After Parkinson’s Trial Milestone. The Real Test Comes in Q3 - Bez Kabli
BioVie (BIVI) Rallies +1.53% as Bulls Target $1.40 2026-05-20McClellan Summation - Newser
BioVie completes final patient visit in Parkinson's drug trial - Proactive financial news
BioVie (BIVI) Completes Patient Evaluations for Parkinson's Tria - GuruFocus
BioVie completes patient visits in Parkinson’s disease trial By Investing.com - Investing.com Nigeria
BioVie completes patient visits in Parkinson’s disease trial - Investing.com
BioVie Inc. Completes Final Patient Visit in SUNRISE-PD Phase 2 Trial for Bezisterim in Early-Stage Parkinson's Disease - Quiver Quantitative
Experimental Parkinson’s drug bezisterim finishes key trial, results due Q3 - Stock Titan
Why BioVie (BIVI) Just Surged +3.82% — Key Levels Ahead 2026-05-18Most Discussed Stocks - Newser
TradingKey - TradingKey
BioVie | 10-Q: Quarterly report - Moomoo
BIOVIE ($BIVI) Releases Q3 2026 Earnings - Quiver Quantitative
BioVie Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2026 - marketscreener.com
[10-Q] BIOVIE INC. Quarterly Earnings Report - Stock Titan
BioVie nears data readout for potential first treatment targeting long COVID symptoms. - Pluang
BioVie CEO shares insights into long COVID trialICYMI - Proactive financial news
Why BioVie (BIVIW) leadership matters more than you think (Smart Money Outflows) 2026-05-08Analyst Recommended Stocks - newser.com
BioVie (BIVIW) quarterly earnings show no revenue or profit data, raising transparency concerns among market participants.Free Signal Network - Newser
Alumni StoriesCuong Do - Dartmouth Tuck School of Business
BioVie advances long COVID trial, top-line data expected by summer - Proactive financial news
12 Health Care Stocks Moving In Friday's After-Market SessionAkanda (NASDAQ:AKAN), BioVie (NASDAQ:BIVI - Benzinga
BioVie Investor Deadline Approaching - TMX Newsfile
What influences BioVie (BIVIW) stock price action |Crowd Sentiment Stocks - Newser
BioVie Shareholder Notice - TMX Newsfile
BIVIW Price History for Biovie WT Stock - Barchart.com
BioVie to host KOL event highlighting Bezisterim's potential in Parkinson's Disease - Proactive financial news
BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson's Disease ahead of Topline Data in 2Q26, on May 7, 2026 - ChartMill
Why United Rentals Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket - Sahm
BioVie stock dips on pricing $12M securities offering - MSN
BioVie (BIVI) Market Position | Q3 2025: Better Than ExpectedCommunity Driven Stock Picks - Cổng thông tin điện tử tỉnh Tây Ninh
Is BioVie (BIVI) stock showing bullish signals today | BioVie Inc. Delivers 13.5 Percent EPS Beat Topping Analyst EstimatesTrending Entry Points - Cổng thông tin điện tử tỉnh Tây Ninh
BIVIW (BioVie) PS Ratio : (As of Apr. 27, 2026) - GuruFocus
BIVIW (BioVie) Cyclically Adjusted PB Ratio : (As of Apr. 22, 2026) - GuruFocus
BIVIW (BioVie) Cyclically Adjusted PS Ratio : (As of Apr. 27, 2026) - GuruFocus
BIVIW (BioVie) EV-to-EBIT : 0.00 (As of Apr. 22, 2026) - GuruFocus
BioVie Inc (BIVIW) Valuation - GuruFocus
BioVie Inc (BIVIW) Competitors 2026 - GuruFocus
BioVie Inc (BIVIW) Stock HoldersInstitutional & Insider Ownership - GuruFocus
BIVIW (BioVie) Net Income From Continuing Operations : $-17.43 Mil (TTM As of Dec. 2025) - GuruFocus
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):